-
Introducing flexible configuration packages for the Alto Digital SPR System
In today’s challenging economic climate, both biotechs and academic labs are navigating through tough times, particularly when it comes to securing funding for essential equipment and research i...
-
Hello Boston, Meet Nicoya.
We are super excited to introduce our new lab in Boston! Meet the dynamic team behind the launch and discover the capabilities of our innovative instruments. We’re thrilled to share some fantast...
-
Helping scientists succeed in the Bay Area: Meet the team behind our new San Francisco lab
We’re excited to announce the opening of our brand-new lab facility in San Francisco! Meet the team behind this exciting development and explore how we’re supporting drug discovery in the Bay Area...
-
Epitope characterization made easy: How Digital SPR redefines the antibody workflow
Galvanize your productivity with Alto’s epitope binning application: Pre-designed, intuitive, and sample-friendly. Early antibody discovery involves the screening of a large number of molecules to i...
-
From droplets to kinetics: Exploring the fundamentals of digital microfluidics and SPR
Alto™ leverages digital microfluidics technology to streamline SPR workflows by automating and miniaturizing kinetics assays. Not too long ago, the idea of digitizing lab experiments like we digitiz...
-
Become an SPR expert with our 10 tips for success
From assay design to optimization, our top 10 tips will guide you to success! After months of researching various technologies, evaluating surface plasmon resonance (SPR) instruments on the market, an...
-
How does Digital SPR fit into early drug discovery?
Digital surface plasmon resonance (SPR) offers a more automated and versatile method for studying binding properties that determine lead quality and drug efficacy. Biomolecular interactions are at the...
-
Meet Sri: Nicoya’s SVP of Marketing and Product
With Sri’s energy, vision, and strategic direction, we’re ready to leap into the next chapter of our growth. One of the most exciting developments in our year so far has been the addition of Dr. S...
-
Shaping the future of therapeutic antibodies with Digital SPR
We spent a week with innovators of antibody therapeutics to learn how we can enhance development from bench to bedside By Mike Piazza, Associate Director of Applications Development We recently had th...
-
The future of biosimilars: How emerging technologies are paving the way
Next-generation methods that streamline biosimilar expression and characterization are imperative to lowering the cost of development and maximizing market growth. Biosimilars have delivered on their ...